Quantifying Preferences in Drug Benefit‐Risk Decisions

Clinical Pharmacology and Therapeutics- United States

doi 10.1002/cpt.1447

Full Text

Abstract

Available in

Categories

Pharmacology

Date

Authors

Publisher

Wiley

Related search

Patient Preferences: Understanding Risk-Benefit Trade-Offs of Genomic Testing in Chemotherapy Decisions for Breast Cancer Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Quantifying the Loss in Resource Benefit for Risk Based Decision in Digital Business Ecosystem

2007English

Tax–benefit Revealed Social Preferences

Journal of Economic Inequality
SociologyFinanceOrganizational BehaviorEconomicsPolitical ScienceEconometricsHuman Resource Management
2010English

Employee Pay and Benefit Preferences

Relations industrielles
2005English

In Good Company: Risk, Security and Choice in Young People'S Drug Decisions

Sociological Review
SociologyPolitical Science
2007English

Effect Size Measures and Their Benchmark Values for Quantifying Benefit or Risk of Medicinal Products

Biometrical Journal
MedicineUncertaintyStatisticsProbability
2019English

Understanding and Utilizing Patient Preferences in Cancer Treatment Decisions

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Debating Drug Approval Decisions

Cancer Discovery
Oncology
2013Danish

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy